Huron Consulting Group (NASDAQ:HURN) Updates FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) issued an update on its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 6.800-7.600 for the period, compared to the consensus estimate of 6.950. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Huron Consulting Group Price Performance

Shares of NASDAQ:HURN traded up $0.03 during midday trading on Tuesday, reaching $125.33. The company’s stock had a trading volume of 396,891 shares, compared to its average volume of 110,694. The business’s fifty day simple moving average is $125.65 and its 200-day simple moving average is $117.22. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. Huron Consulting Group has a fifty-two week low of $84.26 and a fifty-two week high of $133.96. The company has a market capitalization of $2.22 billion, a P/E ratio of 27.25 and a beta of 0.59.

Huron Consulting Group (NASDAQ:HURN) last posted its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. As a group, equities research analysts expect that Huron Consulting Group will post 6.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

HURN has been the subject of several research reports. Barrington Research lifted their target price on Huron Consulting Group from $137.00 to $142.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Benchmark reissued a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a report on Wednesday, October 30th. Wedbush started coverage on shares of Huron Consulting Group in a research note on Monday, February 3rd. They issued an “outperform” rating on the stock. Finally, StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $133.00.

Insiders Place Their Bets

In other news, Director James H. Roth sold 2,000 shares of Huron Consulting Group stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $126.03, for a total transaction of $252,060.00. Following the transaction, the director now directly owns 48,534 shares of the company’s stock, valued at $6,116,740.02. This trade represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director H Eugene Lockhart sold 1,042 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $122.81, for a total transaction of $127,968.02. Following the completion of the transaction, the director now directly owns 26,756 shares of the company’s stock, valued at $3,285,904.36. This trade represents a 3.75 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,584 shares of company stock worth $1,067,539. Insiders own 2.02% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.